Anthony P. Davenport
Clinical Pharmacology Unit
University of Cambridge
Level 6
Centre for Clinical Investigation
UK
Name/email consistency: high
- International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Davenport, A.P., Alexander, S.P., Sharman, J.L., Pawson, A.J., Benson, H.E., Monaghan, A.E., Liew, W.C., Mpamhanga, C.P., Bonner, T.I., Neubig, R.R., Pin, J.P., Spedding, M., Harmar, A.J. Pharmacol. Rev. (2013)
- Evidence for a novel vasospastic transmitter system, neuromedin U, in the equine digital circulation. Mitchell, J.D., Kuc, R.E., Maguire, J.J., Davenport, A.P. Vet. J. (2010)
- Endothelin. Davenport, A.P., Maguire, J.J. Handb. Exp. Pharmacol (2006)
- International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Davenport, A.P., Bonner, T.I., Foord, S.M., Harmar, A.J., Neubig, R.R., Pin, J.P., Spedding, M., Kojima, M., Kangawa, K. Pharmacol. Rev. (2005)
- Down-regulation of ETA receptors in ETB receptor-deficient mice. Davenport, A.P., Kuc, R.E. J. Cardiovasc. Pharmacol. (2004)
- Peptide and trace amine orphan receptors: prospects for new therapeutic targets. Davenport, A.P. Curr. Opin. Pharmacol (2003)
- Of mice and men: advances in endothelin research and first antagonist gains FDA approval. Davenport, A.P., Maguire, J.J. Trends Pharmacol. Sci. (2002)
- International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Davenport, A.P. Pharmacol. Rev. (2002)
- The endothelin system in human saphenous vein graft disease. Davenport, A.P., Maguire, J.J. Curr. Opin. Pharmacol (2001)
- Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2. Davenport, A.P., Kuc, R.E. J. Cardiovasc. Pharmacol. (2000)
